ARCHIVES

October issue of Business & Regulatory Report included.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

ORI Misconduct Findings Announced In Two Cases

July 12, 1996

OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB

October 13, 1989

Brooks Wins ACS Award. NCI Would Get $4.725 Billion, 12% Increase, In Bush Budget.

February 8, 2002